Pharmaceuticals, Biotechnology and Life Sciences
Montrouge, France, March 2, 2023 DBV Technologies announces filing of 2022 Annual Report on Form 10-K and 2022 Universal Registration…
IRVINE, Calif., March 02, 2023 (GLOBE NEWSWIRE) — Biomerica, Inc. (NASDAQ: BMRA) (“Biomerica”), a global provider of advanced medical products,…
SAN DIEGO, March 02, 2023 (GLOBE NEWSWIRE) — Oncternal Therapeutics, Inc. (Nasdaq: ONCT), a clinical-stage biopharmaceutical company focused on the…
Not for distribution to U.S. news wire services or dissemination in the United States WINNIPEG, Manitoba, March 02, 2023 (GLOBE…
Focused on Increasing Awareness and Enhancing Stockholder Value LAS VEGAS, NV, March 01, 2023 (GLOBE NEWSWIRE) — via NewMediaWire –…
Three times more patients treated with Kevzara achieved sustained remission compared to placebo in Phase 3 trial Kevzara now approved…
CLINUVEL’s CYACÊLLE CLINUVEL today launched CYACÊLLE, a next generation of polychromatic solar care. CYACÊLLE is designed to protect skin from…
Transaction Solidifies Company’s Near-Term Strategic Focus on Advancing Clinical Development of NX-13Company Remains On-Track to Initiate the NX-13 Phase 2…
THE WOODLANDS, Texas, Feb. 28, 2023 (GLOBE NEWSWIRE) — Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX), will release its fourth quarter 2022…
Conference Call and Webcast to be held March 7, 2023 at 8:00 a.m. Eastern TimeYARDLEY, Pa., Feb. 28, 2023 (GLOBE…